CL2015003803A1 - Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria. - Google Patents
Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.Info
- Publication number
- CL2015003803A1 CL2015003803A1 CL2015003803A CL2015003803A CL2015003803A1 CL 2015003803 A1 CL2015003803 A1 CL 2015003803A1 CL 2015003803 A CL2015003803 A CL 2015003803A CL 2015003803 A CL2015003803 A CL 2015003803A CL 2015003803 A1 CL2015003803 A1 CL 2015003803A1
- Authority
- CL
- Chile
- Prior art keywords
- lactea
- immune response
- improve immune
- response capacity
- osteopontin
- Prior art date
Links
- 230000028993 immune response Effects 0.000 title abstract 2
- 102000004264 Osteopontin Human genes 0.000 title 1
- 108010081689 Osteopontin Proteins 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Marine Sciences & Fisheries (AREA)
- Dispersion Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361843185P | 2013-07-05 | 2013-07-05 | |
| EP13175267 | 2013-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015003803A1 true CL2015003803A1 (es) | 2016-08-05 |
Family
ID=48740972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015003803A CL2015003803A1 (es) | 2013-07-05 | 2015-12-31 | Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria. |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US9956283B2 (enExample) |
| EP (1) | EP3016673B1 (enExample) |
| JP (1) | JP6509833B2 (enExample) |
| KR (1) | KR102307002B1 (enExample) |
| CN (1) | CN105407910B (enExample) |
| AU (1) | AU2014286123B2 (enExample) |
| BR (1) | BR112016000067B1 (enExample) |
| CA (1) | CA2916821C (enExample) |
| CL (1) | CL2015003803A1 (enExample) |
| DK (1) | DK3016673T3 (enExample) |
| EA (1) | EA034654B1 (enExample) |
| ES (1) | ES2656474T3 (enExample) |
| MX (1) | MX369925B (enExample) |
| NZ (1) | NZ715430A (enExample) |
| PH (1) | PH12015502844B1 (enExample) |
| PL (1) | PL3016673T3 (enExample) |
| PT (1) | PT3016673T (enExample) |
| WO (1) | WO2015001092A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102967831B1 (ko) * | 2018-04-25 | 2026-05-20 | 헬쓰 앤드 해피니스 (에이치＆에이치) 홍콩 리미티드 | 의약으로 사용하기 위한 오스테오폰틴 및 2'-푸코실락토오스의 조합물 |
| US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
| CN113424962A (zh) * | 2020-09-21 | 2021-09-24 | 黑龙江飞鹤乳业有限公司 | 提高免疫力的营养组分、含有其的食品或保健品及其用途 |
| EP4326758A4 (en) * | 2021-04-20 | 2025-03-19 | University of Cincinnati | A vaccine adjuvant for infectious diseases |
| CN113475720B (zh) * | 2021-06-15 | 2023-07-25 | 合生元（广州）健康产品有限公司 | 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用 |
| EP4472656A1 (en) * | 2022-01-31 | 2024-12-11 | Société des Produits Nestlé S.A. | Compositions comprising osteopontin (opn) |
| CN117337994A (zh) * | 2023-10-11 | 2024-01-05 | 黑龙江飞鹤乳业有限公司 | 功能性组合物及该组合物的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998056405A1 (en) | 1997-06-10 | 1998-12-17 | Whitehead Institute For Biomedical Research | A method of modulating immune response with osteopontin |
| CA2293492A1 (en) * | 1997-06-11 | 1998-12-17 | Martin Berry | Cns neuroregenerative compositions and methods of use |
| CA2370129A1 (en) | 1999-04-15 | 2000-10-26 | Children's Medical Center Corporation | Methods and compositions for modulating an immune response |
| US7259243B2 (en) | 2000-01-07 | 2007-08-21 | Arla Foods Amba | Process for isolation of osteopontin from milk |
| WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
| AU2003239589A1 (en) * | 2002-05-24 | 2003-12-12 | Schering-Plough Ltd. | Eta-1 gene and methods for use |
| ES2444843T3 (es) * | 2003-09-18 | 2014-02-27 | Arla Foods Amba | Fórmula para lactantes |
| EP1667537B1 (en) * | 2003-09-18 | 2013-11-06 | Arla Foods Amba | Infant formula |
| KR20090123115A (ko) | 2008-05-27 | 2009-12-02 | 한국생명공학연구원 | 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법 |
| AU2012222312B2 (en) * | 2011-03-03 | 2017-06-08 | Arla Foods Amba | Method for isolating osteopontin using feeds containing cmp or casein species |
| US20150344534A1 (en) * | 2011-12-07 | 2015-12-03 | Arla Foods Amba | Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants |
-
2014
- 2014-07-04 MX MX2016000107A patent/MX369925B/es active IP Right Grant
- 2014-07-04 NZ NZ715430A patent/NZ715430A/en unknown
- 2014-07-04 CN CN201480038124.7A patent/CN105407910B/zh active Active
- 2014-07-04 EP EP14735964.0A patent/EP3016673B1/en active Active
- 2014-07-04 US US14/903,049 patent/US9956283B2/en active Active
- 2014-07-04 BR BR112016000067-6A patent/BR112016000067B1/pt active IP Right Grant
- 2014-07-04 EA EA201690057A patent/EA034654B1/ru not_active IP Right Cessation
- 2014-07-04 DK DK14735964.0T patent/DK3016673T3/da active
- 2014-07-04 KR KR1020167002892A patent/KR102307002B1/ko active Active
- 2014-07-04 PT PT147359640T patent/PT3016673T/pt unknown
- 2014-07-04 ES ES14735964.0T patent/ES2656474T3/es active Active
- 2014-07-04 AU AU2014286123A patent/AU2014286123B2/en active Active
- 2014-07-04 WO PCT/EP2014/064339 patent/WO2015001092A1/en not_active Ceased
- 2014-07-04 JP JP2016522645A patent/JP6509833B2/ja active Active
- 2014-07-04 CA CA2916821A patent/CA2916821C/en active Active
- 2014-07-04 PL PL14735964T patent/PL3016673T3/pl unknown
-
2015
- 2015-12-21 PH PH12015502844A patent/PH12015502844B1/en unknown
- 2015-12-31 CL CL2015003803A patent/CL2015003803A1/es unknown
-
2018
- 2018-04-04 US US15/945,517 patent/US10772955B2/en not_active Ceased
-
2022
- 2022-01-12 US US17/573,707 patent/USRE50281E1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10772955B2 (en) | 2020-09-15 |
| CN105407910A (zh) | 2016-03-16 |
| AU2014286123B2 (en) | 2019-02-28 |
| MX369925B (es) | 2019-11-25 |
| NZ715430A (en) | 2022-01-28 |
| CA2916821C (en) | 2023-10-03 |
| BR112016000067A2 (enExample) | 2017-09-05 |
| EA034654B1 (ru) | 2020-03-03 |
| EP3016673A1 (en) | 2016-05-11 |
| USRE50281E1 (en) | 2025-01-28 |
| KR102307002B1 (ko) | 2021-10-05 |
| EA201690057A1 (ru) | 2016-07-29 |
| US20160136268A1 (en) | 2016-05-19 |
| DK3016673T3 (da) | 2018-01-29 |
| CA2916821A1 (en) | 2015-01-08 |
| MX2016000107A (es) | 2016-06-07 |
| CN105407910B (zh) | 2019-12-03 |
| KR20160030960A (ko) | 2016-03-21 |
| ES2656474T3 (es) | 2018-02-27 |
| BR112016000067B1 (pt) | 2022-08-30 |
| AU2014286123A1 (en) | 2016-01-21 |
| PT3016673T (pt) | 2018-01-30 |
| JP2016529217A (ja) | 2016-09-23 |
| JP6509833B2 (ja) | 2019-05-08 |
| PL3016673T3 (pl) | 2018-04-30 |
| PH12015502844A1 (en) | 2016-03-28 |
| US9956283B2 (en) | 2018-05-01 |
| WO2015001092A1 (en) | 2015-01-08 |
| PH12015502844B1 (en) | 2016-03-28 |
| US20180289798A1 (en) | 2018-10-11 |
| EP3016673B1 (en) | 2017-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200035I1 (hu) | Konjugált burokszaccharid antigéneket tartalmazó immunogén készítmények és alkalmazásaik | |
| IL271110A (en) | Antibodies specific for flt3 and their uses | |
| IL259075A (en) | Subcutaneous formulations of anti-cd38 antibodies and their uses | |
| CL2015002562A1 (es) | Anticuerpos e inmunoconjugados anti-b7-h4 | |
| CL2016002772A1 (es) | Composiciones de insulina de rápida acción | |
| EP3152616A4 (en) | Efficient, dynamic, high contrast lensing with applications to imaging, illumination and projection | |
| UY34721A (es) | Anticuerpos anti-hla-b*27 y usos de éstos. | |
| MA40579A (fr) | Anticorps anti-cll-1 et immunoconjugués | |
| JOP20140114B1 (ar) | مركبات حلقية غير متجانسة واستخداماتها | |
| TWD179460S (zh) | 機車 | |
| PL3058936T3 (pl) | Kompozycja peptydów i jej zastosowania | |
| HUE034927T2 (hu) | Szilícium gél kompozíció és ennek alkalmazása | |
| PT3463435T (pt) | Anticorpos para alfa-sinucleína e as suas utilizações | |
| UY34406A (es) | Compuestos y métodos para mejorar la respuesta inmune innata | |
| TWD168670S (zh) | 流體匣之部分 | |
| HUE063307T2 (hu) | Rák és vírusfertõzések kezelésére szolgáló immunreceptor-moduláció | |
| EP2968553A4 (en) | ANTIBODY FORMULATIONS | |
| HUE053787T2 (hu) | Viszkozitást javító súrlódáscsökkentõk | |
| EA201591712A1 (ru) | Антибиотические композиции на основе цефтолозана | |
| EP2983661A4 (en) | FORMULATIONS OF OXABICYCLOHEPTANES AND OXABICYCLOHENDS | |
| IL259202A (en) | Modified immune cells and uses thereof | |
| HUE047484T2 (hu) | Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására | |
| HUE045150T2 (hu) | Anti-CD26 antitestek és alkalmazásaik | |
| HUE055277T2 (hu) | Dihomo-gamma-linolénsavat tartalmazó mikrobális olaj és dihomo-gamma-linolénsavat tartalmazó mikrobális biomassza | |
| BR112017015159A2 (pt) | preparação e uso de produtos plaquetários |